BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1508 related articles for article (PubMed ID: 26348734)

  • 1. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
    Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
    JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical heterogeneity of patients with stool samples testing PCR+/Tox- from a two-step Clostridium difficile diagnostic algorithm.
    Zou J; Leung V; Champagne S; Hinch M; Wong A; Lloyd-Smith E; Nguyen TT; Romney MG; Sharma A; Payne M; Lowe CF
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2355-2359. PubMed ID: 30238342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?
    Sunkesula VC; Kundrapu S; Muganda C; Sethi AK; Donskey CJ
    Clin Infect Dis; 2013 Aug; 57(4):494-500. PubMed ID: 23645849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
    Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
    Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Clostridium difficile PCR Cycle Threshold-Predicted Toxin Reporting in Pediatric Patients.
    Schwenk HT; Bio LL; Kruger JF; Banaei N
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):44-50. PubMed ID: 30476169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-based diagnosis of Clostridium difficile infection is associated with reduced mortality.
    Avni T; Babich T; Ben-Zvi H; Atamna A; Yahav D; Shepshelovich D; Leibovici-Weissman Y; Bishara J
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1137-1142. PubMed ID: 29627950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
    Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
    J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.
    Tsai CS; Hung YP; Lee JC; Lee NY; Chen PL; Syue LS; Li MC; Li CW; Ko WC
    J Microbiol Immunol Infect; 2018 Apr; 51(2):243-250. PubMed ID: 28089100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
    Catanzaro M; Cirone J
    Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.
    Origüen J; Corbella L; Orellana MÁ; Fernández-Ruiz M; López-Medrano F; San Juan R; Lizasoain M; Ruiz-Merlo T; Morales-Cartagena A; Maestro G; Parra P; Villa J; Delgado R; Aguado JM
    Clin Microbiol Infect; 2018 Apr; 24(4):414-421. PubMed ID: 28811244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
    Kumar S; Pollok R; Muscat I; Planche T
    J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study.
    Cioni G; Viale P; Frasson S; Cipollini F; Menichetti F; Petrosillo N; Brunati S; Spigaglia P; Vismara C; Bielli A; Barbanti F; Landini G; Panigada G; Gussoni G; Bonizzoni E; Gesu GP;
    BMC Infect Dis; 2016 Nov; 16(1):656. PubMed ID: 27825317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
    Li Y; Qian J; Queener E; Shen B
    Inflamm Bowel Dis; 2013 Feb; 19(2):397-403. PubMed ID: 23328770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.